The high significance of CD8+ T cells in the immunotherapy of kidney cancer and the results of single-cell sequencing analysis (CD8 + T cells were significantly differentially expressed in KIRC and kidney tissue) can be used to construct a prognostic model of CD8+ T cell-associated genes to guide clinical decisions in KIRC. This evidence concerns the gene CD8A and kidney cancer.